Digestive Diseases and Sciences

, Volume 53, Issue 5, pp 1358–1363 | Cite as

Ethnicity and Nonalcoholic Fatty Liver Disease in an Obesity Clinic: The Impact of Triglycerides

  • Eric R. Kallwitz
  • Mrudula Kumar
  • Radhika Aggarwal
  • Reed Berger
  • Jennifer Layden-Almer
  • Neil Gupta
  • Scott J. Cotler
Original Paper


Nonalcoholic fatty liver disease (NAFLD) is a growing problem that is associated with the metabolic syndrome. The goal of the present study was to evaluate for ethnic differences in NAFLD and clinical correlates of NAFLD. The study population consisted of 567 patients seen at an urban obesity clinic. Elevated aminotransferase levels were used as a surrogate marker for NAFLD. The prevalence of elevated aminotransferases was highest in Hispanics (39%), followed by Caucasians (28%), and African Americans (12%). In univariate analysis, elevated aminotransferase levels were associated with ethnicity (Hispanic > African American, P < 0.001, and Caucasian > African American P = 0.030), hypertriglyceridemia (P < 0.001), and male gender (P < 0.001). The pattern of results was confirmed in multivariate analysis, except that the differences between Caucasians and African Americans was no longer significant. In conclusion, in an obesity clinic population, elevated aminotransferase levels and hypertriglyceridemia were most common in Hispanics and least common in African Americans.


Fatty liver Ethnology Triglycerides Obesity 


  1. 1.
    Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555PubMedCrossRefGoogle Scholar
  2. 2.
    Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497 (2001)Google Scholar
  3. 3.
    Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 287:356–359PubMedCrossRefGoogle Scholar
  4. 4.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231PubMedCrossRefGoogle Scholar
  5. 5.
    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850PubMedCrossRefGoogle Scholar
  6. 6.
    Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMedCrossRefGoogle Scholar
  7. 7.
    Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37:1202–1219PubMedCrossRefGoogle Scholar
  8. 8.
    Angulo P, Keach JC, Batts KP, Lindor KD (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356–1362PubMedCrossRefGoogle Scholar
  9. 9.
    Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29:664–669PubMedCrossRefGoogle Scholar
  10. 10.
    Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100PubMedCrossRefGoogle Scholar
  11. 11.
    Garcia-Monzon C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A, Larranaga E, Moreno-Otero R (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33:716–724PubMedCrossRefGoogle Scholar
  12. 12.
    Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T (2000) Liver fibrosis in overweight patients. Gastroenterology 118:1117–1123PubMedCrossRefGoogle Scholar
  13. 13.
    Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71–79PubMedCrossRefGoogle Scholar
  14. 14.
    Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395PubMedCrossRefGoogle Scholar
  15. 15.
    Caldwell SH, Harris DM, Patrie JT, Hespenheide EE (2002) Is NASH underdiagnosed among African Americans? Am J Gastroenterol 97:1496–1500PubMedCrossRefGoogle Scholar
  16. 16.
    Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ (2005) Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 41:426–429PubMedCrossRefGoogle Scholar
  17. 17.
    Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE (2005) Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 115:e561–565PubMedCrossRefGoogle Scholar
  18. 18.
    Solga SF, Clark JM, Alkhuraishi AR, Torbenson M, Tabesh A, Schweitzer M, Diehl AM, Magnuson TH (2005) Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis 1:6–11PubMedCrossRefGoogle Scholar
  19. 19.
    Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, Terrault NA (2005) Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41:372–379PubMedCrossRefGoogle Scholar
  20. 20.
    Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137:1–10PubMedGoogle Scholar
  21. 21.
    Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988–1994. Diabetes Care 21:518–524PubMedCrossRefGoogle Scholar
  22. 22.
    Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: national health and nutrition examination survey 1999–2002. Diabetes Care 29:1263–1268PubMedCrossRefGoogle Scholar
  23. 23.
    Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R (1996) Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45:1119–1124PubMedCrossRefGoogle Scholar
  24. 24.
    Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343–1351PubMedGoogle Scholar
  25. 25.
    Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845PubMedCrossRefGoogle Scholar
  26. 26.
    Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH (2006) The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 55:1604–1609PubMedCrossRefGoogle Scholar
  27. 27.
    Hoffman RP (2006) Increased fasting triglyceride levels are associated with hepatic insulin resistance in Caucasian but not African-American adolescents. Diabetes Care 29:1402–1404PubMedCrossRefGoogle Scholar
  28. 28.
    Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC (2005) Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 165:1395–1400PubMedCrossRefGoogle Scholar
  29. 29.
    Bard JM, Charles MA, Juhan-Vague I, Vague P, Andre P, Safar M, Fruchart JC, Eschwege E (2001) Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (bigpro) 1 study. Arterioscler Thromb Vasc Biol 21:407–414PubMedGoogle Scholar
  30. 30.
    Florez H, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Castillo-Florez S, Lee D, Goldberg R (2006) Increased apolipoprotein c-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis 188:134–141PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Eric R. Kallwitz
    • 1
    • 2
  • Mrudula Kumar
    • 1
  • Radhika Aggarwal
    • 1
  • Reed Berger
    • 1
  • Jennifer Layden-Almer
    • 1
  • Neil Gupta
    • 1
  • Scott J. Cotler
    • 1
  1. 1.Department of MedicineUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Section of Digestive Diseases and Nutrition (MC 716)ChicagoUSA

Personalised recommendations